/Lists

Biotech Investors & VC Firms in Middle East & North Africa

209 firms in this list, with a median first check of $500K. 53 of them lead rounds. Generated from verified public data and updated continuously.

Blue Horizon Corporation
ZurichSeed–Growth
14 people
AAF Management Ltd.
WashingtonPre-Seed–Series A
4 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
Antler Australia
SydneyPre-Seed–Series C$3M – $10M
17 people
Samsung Ventures
SeoulSeries A
26 people
Swanlaab Venture Factory
MadridSeed–Series A$540K – $3.2M
23 people
Intrepid Growth Partners
TorontoGrowth
28 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
SVG Ventures | THRIVE
Santa ClaraPre-Seed–Series A$10K – $100K
27 people
Vibe Capital
San FranciscoPre-Seed–Series A$250K – $500K
3 people
Georgian
Toronto, OntarioSeries C–Growth$25M – $100M
18 people
Decacorn Capital
SingaporeSeed–Series B$300K – $600K
17 people
KOMPAS VC
HørsholmPre-Seed–Series B$1.1M – $5.4M
15 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage
15 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
16 people
Stray Dog Capital
LeawoodPre-Seed–Series A$100K – $1M
7 people
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
Remiges Ventures, Inc.
SeattleSeed
21 people
Debiopharm Innovation Fund
LausannePre-Seed–Series A$1M – $5M
17 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
FAST — by GETTYLAB
San FranciscoPre-Seed–Seed$100K
1 person
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
Ocean Azul Partners
Coral GablesSeed–Series A$500K – $2M
8 people
Accelmed Partners
MiamiSeries A–Growth
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.